Skip to main content
Clinical Trials/NCT04336358
NCT04336358
Unknown
Not Applicable

Telemedicine Versus Standard Care for First Trimester Abortion in South Africa: a Randomized Controlled Noninferiority Trial

University of Cape Town4 sites in 1 country900 target enrollmentFebruary 27, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Abortion in First Trimester
Sponsor
University of Cape Town
Enrollment
900
Locations
4
Primary Endpoint
Proportion of women who took the abortion pills as instructed
Last Updated
5 years ago

Overview

Brief Summary

The study aim to determine if medical abortion facilitated by a physician online (s.c. telemedicine), combined with a simplified physical exam, is equally effective, safe and acceptable to women in South Africa as standard medical abortion care.

Detailed Description

The proposed study is non-inferiority randomized controlled trial that will investigate the safety, effectiveness and acceptability for women of early medical abortion performed through telemedicine, compared to standard care in South Africa. Standard care, in the Western Cape, includes face to face eligibility screening, counselling and information with a nurse or physician, as well as an ultrasound to confirm the gestational age of the pelvic exam. The intervention will include a pelvic exam and gestatonal age based on LMP assessment and uterine size by bimanual palpation. Eligibility screening, counselling and information will occur through an existing online telemedicine application, content and language-adapted to suit women in South Africa, and managed by a HPCSA certified doctor. The study is a non-inferiority study. Our hypothesis is that the intervention is not inferior to standard care with respect to safety, effectiveness and acceptability. The study is performed to provide an alternate model of abortion care to be applied in settings where abortion is in any way restricted and increase access to safe abortion. Importantly the study is planned for a context where abortion services are legal but restricted by stigma. South Africa therefore provides a uniquely suited setting for this study.

Registry
clinicaltrials.gov
Start Date
February 27, 2020
End Date
November 15, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Deborah Constant, Dr

Director, Head of Women's Health Research Unit, Principal Investigator, Senior Researcher

University of Cape Town

Eligibility Criteria

Inclusion Criteria

  • Able to read and write
  • Able to speak English, IsiXhosa or Afrikaans
  • Gestational age \<9 wks 2 days
  • In possession of a smartphone

Exclusion Criteria

  • Contraindication to medical abortion

Outcomes

Primary Outcomes

Proportion of women who took the abortion pills as instructed

Time Frame: 5 days after abortion consultation

Proportion of women who successfully followed through with the abortion consultation and took the abortion pills as instructed

Rate of complete abortion.

Time Frame: 6 weeks after abortion consultation

Effectiveness Rate of complete abortion. i.e. terminated pregnancy, without need of surgical or medical intervention or persistent bleeding within 6 weeks of the abortion initiation.

Secondary Outcomes

  • Proportion of women that were satisfied or very satisfied with their abortion consultation(6 weeks after abortion consultation)
  • Percentage of women visiting emergency hospital visit for abortion-related symptoms(5 days after abortion consultation)
  • Percentage of women hospitalised for abortion complications(5 days after abortion consultation)
  • Rate of blood transfusion for heavy bleeding(5 days after abortion consultation)
  • Percentage of women preferring telemedicine to standard care(6 weeks after abortion consultation)

Study Sites (4)

Loading locations...

Similar Trials